Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic- related Liver Diseases and Hepatocellular Carcinoma.
Conclusion: Plant and food-derived sterols and triterpenoids (TTP) possess antioxidant, metabolic-regulating, immunomodulatory, and anti-inflammatory activities, as well as they are recognized as anticancer agents, suggesting their application strongly as an alternative therapy in some chronic diseases. Thus, it is interesting to review current reports about them as hepatoprotective agents, but also because they structurally resemble cholesterol, sexual hormones, corticosteroids and bile acids due to the presence of the steroid nucleus, so they all can share pharmacological properties through activating nuclear and membrane receptors. Therefore, sterols and TTP appear as a feasible option for the prevention and treatment of chronic metabolic-related liver diseases, cirrhosis, and HCC.
PMID: 30806308 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Isabel SC, Eduardo FM, Raquel CC, Gabriel BC, Rosa BA Tags: Curr Pharm Biotechnol Source Type: research
More News: Alcoholism | Alternative and Complementary Therapies | Antidoxidants | Autoimmune Disease | Bile | Biotechnology | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | Corticosteroid Therapy | Fatty Liver Disease (FLD) | Hepatocellular Carcinoma | Herbs | Hormones | Liver | Liver Cancer | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Urology & Nephrology